Fulcrum Therapeutics prices upsized public offering of 9.6M shares at $13.00, expected gross proceeds of $125M

Fulcrum Therapeutics, Inc.

Offered 9,615,384 shares at $13.00 per share; gross proceeds of $125 million.
Underwriters granted 30-day option to purchase up to an additional 1,442,307 shares.
Net proceeds estimated at $117.3M ($134.9M if option fully exercised).
Goldman Sachs, SVB Securities, Piper Sandler acting as joint book-running managers.
Offering expected to close on January 20, 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Fulcrum Therapeutics, Inc. entered into underwriting agreement with Goldman Sachs & Co. LLC, SVB Securities LLC and Piper Sandler & Co., as representatives of the several underwriters valued at approximately $117.3 million (effective 2023-01-17).

Action: entry
Agreement: underwriting
Counterparty: Goldman Sachs & Co. LLC, SVB Securities LLC and Piper Sandler & Co., as representatives of the several underwriters
Value: approximately $117.3 million
Effective: 2023-01-17

Exact text from the filing

On January 17, 2023, Fulcrum Therapeutics, Inc., or Fulcrum, entered into an underwriting agreement with Goldman Sachs & Co. LLC, SVB Securities LLC and Piper Sandler & Co., as the representatives of the several underwriters, or the Underwriters, relating to an underwritten public offering of 9,615,384 shares of its common stock, par value $0.001 per share, at a price to the public of $13.00 per share, less underwriting discounts and commissions.

View on SEC.gov

Browse all material agreements →

Fulcrum Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-010273

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.